Login

Register

Login

Register

Vertex Pharma (VRTX) Breaks Major Support, Watch This Trade Level

Leading biotechnology stock, Vertex Pharmaceuticals (VRTX), came under heavy selling pressure last week. The stock fell to a new 52-week low after announcing that it will halt the development of its rare lung cancer drug. Vertex Pharma (VRTX) stock is now trading below its important 200-week moving average. This puts the stock in a weak technical position on the charts and often signals further downside in the shares. 

The next major support level for Vertex Pharma stock will be around the $170.00 area. This is a level where the stock broke out of a major sideways base in October 2019. When a stock backtests a former breakout area it will often serve as excellent chart support. This is a spot where I would look to be a buyer of the popular biotech stock.  

Get EVERY trade Nick is taking with his members right here…

Get all of Nick’s OPTIONS Swing Trades Here    <<>>    Get all of Nick’s STOCK Swing Trades Here